Given the roles that IKKα and NIK have in the transcriptional induction and responses that underpin the development and maintenance of key phenotypic outcomes we associate with ‘hallmarks’ of cancer described above, we consider the status of these proteins in both solid tumours and haematological cancers and how they may represent potential drug targets in each. The gene discussed is CHUK; the disease is cancer.